Session Information

  • WCLC 2022

    2022 World Conference on Lung Cancer

    As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.

    Presentation Date(s):  
    • August 6 - 9, 2022
    • Total Presentations: 2015

    All times listed are in Vienna, Austria Time, CEST (UTC+2:00)

    PL - Plenary
    IBS - Interactive Breakfast Session (in-person attendees only)
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    P - Posters
    EP - ePosters
    WS - Workshops
    LA – Lectureship Awards
    IS - Industry Symposium

Filter Results:

Show Only CME Accredited Sessions

  • +

    ES02 - Management of Lung Cancer in the Era of COVID-19 I

    • 10:45 - 11:45
    • 8/07/2022
    • Location: Hall C2
    • IASLC CME Accredited
    • Type: Education Session
    • Track: Management of Lung Cancer in the Era of COVID-19
    • +

      Session Moderator

      10:59 - 11:11  |  Presenter: Marina Chiara Garassino

      • Abstract

      Loading...

    • +

      Session Moderator

      10:59 - 11:11  |  Presenter: Christian Grohe

      • Abstract

      Loading...

    • +

      ES02.01 - Session Introduction

      10:45 - 10:46  |  Presenter: Marina Chiara Garassino

      • Abstract

      Loading...

    • +

      ES02.02 - Session Introduction

      10:46 - 10:47  |  Presenter: Christian Grohe

      • Abstract

      Loading...

    • +

      ES02.03 - Impact of the COVID-19 Pandemic on Lung Cancer Diagnosis and Screening

      10:47 - 10:59  |  Presenter: Betty Tong

      • Abstract

      Loading...

    • +

      ES02.04 - Impact of the COVID-19 Pandemic on Surgery

      10:59 - 11:11  |  Presenter: Leanne Ashrafian

      • Abstract

      Loading...

    • +

      ES02.05 - Impact of the COVID-19 Pandemic on Radiotherapy

      11:11 - 11:23  |  Presenter: Umberto Ricardi

      • Abstract

      Loading...

    • +

      ES02.06 - Impact of the COVID-19 Pandemic on Systemic Treatment

      11:23 - 11:35  |  Presenter: Wilfried Ernst Erich Eberhardt

      • Abstract

      Loading...

    • +

      ES02.07 - Live Q&A

      11:35 - 11:45

      • Abstract

      Loading...

  • +

    ES03 - Synchronous Oligometastatic NSCLC: Practical Implications

    • 10:45 - 11:45
    • 8/07/2022
    • Location: Strauss 1/2
    • IASLC CME Accredited
    • Type: Education Session
    • Track: Metastatic Non-small Cell Lung Cancer - Oligometastatic Disease
    • +

      Session Moderator

      10:47 - 10:59  |  Presenter: Hans Hoffmann

      • Abstract

      Loading...

    • +

      Session Moderator

      10:47 - 10:59  |  Presenter: Daniel SW Tan

      • Abstract

      Loading...

    • +

      ES03.01 - Session Introduction

      10:45 - 10:46  |  Presenter: Daniel SW Tan

      • Abstract

      Loading...

    • +

      ES03.02 - Session Introduction

      10:46 - 10:47  |  Presenter: Hans Hoffmann

      • Abstract

      Loading...

    • +

      ES03.03 - Synchronous Oligometastatic NSCLC 2022 Where Are We Now

      10:47 - 10:59  |  Presenter: Jeffrey Dee Bradley

      • Abstract

      Loading...

    • +

      ES03.04 - Concept 1: Brain Only Disease

      10:59 - 11:11  |  Presenter: Paul Martin Putora

      • Abstract

      Loading...

    • +

      ES03.05 - Concept 2: Bulky Thoracic Disease

      11:11 - 11:23  |  Presenter: Ben Solomon

      • Abstract

      Loading...

    • +

      ES03.06 - Concept 3: cT1bN0, Single Adrenal Met: Surgery or Radiotherapy; Sequencing with Systemic Treatment

      11:23 - 11:35  |  Presenter: Isabelle Opitz

      • Abstract

      Loading...

    • +

      ES03.07 - Live Q&A

      11:35 - 11:45

      • Abstract

      Loading...

  • +

    MA01 - Molecular Subtypes and Prognostic Factors for SCLC and Neuroendocrine Tumors

    • 10:45 - 11:45
    • 8/07/2022
    • Location: Hall C7
    • Not for CME Credit
    • Type: Mini Oral
    • Track: Small Cell Lung Cancer and Neuro-Endocrine Tumors
    • +

      Session Moderator

      10:45 - 10:46  |  Presenter: Fabio Pagni

      • Abstract

      Loading...

    • +

      Session Moderator

      10:45 - 10:46  |  Presenter: Ferdinandos Skoulidis

      • Abstract

      Loading...

    • +

      MA01.01 - Session Introduction

      10:45 - 10:46  |  Presenter: Fabio Pagni

      • Abstract

      Loading...

    • +

      MA01.02 - Session Introduction

      10:46 - 10:47  |  Presenter: Ferdinandos Skoulidis

      • Abstract

      Loading...

    • +

      MA01.03 - Exploiting DNA Methylation for Classification of SCLC Subtypes from Liquid Biopsies Using a Robust Machine Learning Approach

      10:47 - 10:52  |  Presenter: Simon Heeke

      • Abstract

      Loading...

    • +

      MA01.04 - Molecular Subtypes of Surgically Resected Small Cell Lung Cancer: Expression Pattern and Prognostic Relevance

      10:52 - 10:57  |  Presenter: Zsolt Megyesfalvi

      • Abstract

      Loading...

    • +

      MA01.05 - Immuno-microenvironment (TIME) Heterogeneity of Small Cell Lung Cancer (SCLC) Stratified by Molecular Subtypes

      10:57 - 11:02  |  Presenter: Jiyan DONG

      • Abstract

      Loading...

    • +

      MA01.06 - Discussant

      11:02 - 11:12  |  Presenter: Kenneth John O'Byrne

      • Abstract

      Loading...

    • +

      MA01.07 - From Molecular to Histological Characterization of Lung Carcinoids via Computer Vision and Spatial Genomics

      11:12 - 11:17  |  Presenter: émilie Mathian

      • Abstract

      Loading...

    • +

      MA01.08 - Impact of [18F]FDG PET/CT-derived Metabolic Parameters on Outcomes in Extensive-stage SCLC

      11:17 - 11:22  |  Presenter: Giuseppe Lamberti

      • Abstract

      Loading...

    • +

      MA01.09 - Characterising Aggressive Pulmonary Carcinoids Through Integrative Omics Analysis Within the lungNENomics Project

      11:22 - 11:27  |  Presenter: Alexandra Sexton-Oates

      • Abstract

      Loading...

    • +

      MA01.10 - Discussant

      11:27 - 11:37  |  Presenter: Michael Boyer

      • Abstract

      Loading...

    • +

      MA01.11 - Live Q&A

      11:37 - 11:45

      • Abstract

      Loading...

  • +

    MA02 - Molecular Underpinnings of Lung Cancer Histological Differentiation and Targeted Therapeutics

    • 10:45 - 11:45
    • 8/07/2022
    • Location: Hall C8
    • Not for CME Credit
    • Type: Mini Oral
    • Track: Tumor Biology and Biomarkers
    • +

      Session Moderator

      10:45 - 10:45  |  Presenter: Erik Thunnissen

      • Abstract

      Loading...

    • +

      Session Moderator

      10:45 - 10:45  |  Presenter: Rafael Rosell

      • Abstract

      Loading...

    • +

      MA02.01 - Session Introduction

      10:45 - 10:46  |  Presenter: Erik Thunnissen

      • Abstract

      Loading...

    • +

      MA02.02 - Session Introduction

      10:46 - 10:47  |  Presenter: Rafael Rosell

      • Abstract

      Loading...

    • +

      MA02.03 - The Evolution of Lung Neuroendocrine Tumors

      10:47 - 10:52  |  Presenter: Nicolas Alcala

      • Abstract

      Loading...

    • +

      MA02.04 - Molecular Drivers and Therapeutic Targets for Neuroendocrine Transformation in Lung Cancer

      10:52 - 10:57  |  Presenter: Triparna Sen

      • Abstract

      Loading...

    • +

      MA02.05 - Dynamic Mutation Profiles of SCLC Transformation in NSCLC Patients Harboring Concurrent EGFR/TP53/RB1 Mutations

      10:57 - 11:02  |  Presenter: Jie Huang

      • Abstract

      Loading...

    • +

      MA02.06 - Discussant

      11:02 - 11:12  |  Presenter: Yuko Minami

      • Abstract

      Loading...

    • +

      MA02.07 - Aurora A Kinase Inhibition with VIC-1911Potentiates KRASG12C Inhibitor and Overcomes Resistance to Sotorasib in Lung Cancer

      11:12 - 11:17  |  Presenter: Jong Woo Lee

      • Abstract

      Loading...

    • +

      MA02.08 - Trametinib Inhibition of MEK1 2 Upregulates PD-L1 Expression in KRAS-Mutant NSCLC Through ID1 Downregulation

      11:17 - 11:22  |  Presenter: Ander Puyalto

      • Abstract

      Loading...

    • +

      MA02.09 - Impact of Baseline Clinicopathologic and Genomic Features on Outcomes to KRAS G12C Inhibitors in Patients with NSCLC

      11:22 - 11:27  |  Presenter: Giuseppe Lamberti

      • Abstract

      Loading...

    • +

      MA02.10 - Discussant

      11:27 - 11:37  |  Presenter: Sally Lau

      • Abstract

      Loading...

    • +

      MA02.11 - Live Q&A

      11:37 - 11:45

      • Abstract

      Loading...

  • +

    OA01 - Real World Data to Guide Our Daily Needs

    • 10:45 - 11:45
    • 8/07/2022
    • Location: Strauss 3
    • Not for CME Credit
    • Type: Oral
    • Track: Global Health, Health Services Research, and Health Economics
    • +

      Session Moderator

      10:45 - 10:45  |  Presenter: Gyula Ostoros

      • Abstract

      Loading...

    • +

      Session Moderator

      10:45 - 10:45  |  Presenter: Oscar Arrieta

      • Abstract

      Loading...

    • +

      OA01.01 - Session Introduction

      10:45 - 10:46  |  Presenter: Gyula Ostoros

      • Abstract

      Loading...

    • +

      OA01.02 - Session Introduction

      10:46 - 10:47  |  Presenter: Oscar Arrieta

      • Abstract

      Loading...

    • +

      OA01.03 - Lung Cancer in Victoria: Association Between Stage-Specific Receipt of Guideline-Concordant Treatment and Survival

      10:47 - 10:57  |  Presenter: Sanuki Tissera

      • Abstract

      Loading...

    • +

      OA01.04 - Persisting Gaps in Optimal Care of Stage III Non-Small Cell Lung Cancer: An Australian Patterns of Care Analysis

      10:57 - 11:07  |  Presenter: Robert Stirling

      • Abstract

      Loading...

    • +

      OA01.05 - Socio-economic Inequalities in NSCLC Treatment During the Era of Tumour Biomarker Guided Therapy: A Population-based Study

      11:07 - 11:17  |  Presenter: Ruth Pamela Norris

      • Abstract

      Loading...

    • +

      OA01.06 - Project PEER: A Longitudinal Real-World Study to Understand the Experience of Patients With Lung Cancer and Their Caregivers

      11:17 - 11:27  |  Presenter: Upal Basu Roy

      • Abstract

      Loading...

    • +

      OA01.07 - Discussant

      11:27 - 11:37  |  Presenter: Tatiane Caldas Montella

      • Abstract

      Loading...

    • +

      OA01.08 - Live Q&A

      11:37 - 11:45

      • Abstract

      Loading...

  • +

    ES04 - Current Status of Lung Cancer Screening Worldwide

    • 12:00 - 13:00
    • 8/07/2022
    • Location: Hall C1
    • IASLC CME Accredited
    • Type: Education Session
    • Track: Early Detection and Screening
    • +

      Session Moderator

      12:00 - 12:00  |  Presenter: Torsten Gerriet Blum

      • Abstract

      Loading...

    • +

      Session Moderator

      12:00 - 12:00  |  Presenter: Ricardo Sales Santos

      • Abstract

      Loading...

    • +

      Session Moderator

      12:00 - 12:00  |  Presenter: Mónica Castro

      • Abstract

      Loading...

    • +

      ES04.01 - Session Introduction

      12:00 - 12:01  |  Presenter: Torsten Gerriet Blum

      • Abstract

      Loading...

    • +

      ES04.02 - Session Introduction

      12:01 - 12:02  |  Presenter: Ricardo Sales Santos

      • Abstract

      Loading...

    • +

      ES04.03 - Session Introduction

      12:02 - 12:03  |  Presenter: Mónica Castro

      • Abstract

      Loading...

    • +

      ES04.04 - Europe: International Network for Continuous Evidence-Based Optimization of LCS

      12:03 - 12:15  |  Presenter: Matthijs Oudkerk

      • Abstract

      Loading...

    • +

      ES04.05 - Lung Cancer Screening in Asia for Individuals Without a Smoking History

      12:15 - 12:27  |  Presenter: Pan Chyr Yang

      • Abstract

      Loading...

    • +

      ES04.06 - Argentinean National Consensus on LCS; Barriers and Challenges to Implement It in the Context of Latinoamerica LCS Situation

      12:27 - 12:39  |  Presenter: Iris Boyeras Navarro

      • Abstract

      Loading...

    • +

      ES04.07 - Gender Differences in Lung Cancer Screening

      12:39 - 12:51  |  Presenter: Narjust Florez (Duma)

      • Abstract

      Loading...

    • +

      ES04.08 - Live Q&A

      12:51 - 13:00

      • Abstract

      Loading...

  • +

    ES05 - Oncogenic Alterations and Beyond - Novel Treatments

    • 12:00 - 13:00
    • 8/07/2022
    • Location: Hall C2
    • IASLC CME Accredited
    • Type: Education Session
    • Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
    • +

      Session Moderator

      12:00 - 12:00  |  Presenter: Caicun Zhou

      • Abstract

      Loading...

    • +

      Session Moderator

      12:00 - 12:00  |  Presenter: Maximilian Johannes Hochmair

      • Abstract

      Loading...

    • +

      ES05.01 - Session Introduction

      12:00 - 12:01  |  Presenter: Caicun Zhou

      • Abstract

      Loading...

    • +

      ES05.02 - Session Introduction

      12:01 - 12:02  |  Presenter: Maximilian Johannes Hochmair

      • Abstract

      Loading...

    • +

      ES05.03 - Targeting Rarer Events in Known Targets: EGFR Exon20 (EGFR, HER2)

      12:02 - 12:14  |  Presenter: Giannis Mountzios

      • Abstract

      Loading...

    • +

      ES05.04 - All You Need to Know About KRAS

      12:14 - 12:26  |  Presenter: Odd Terje Brustugun

      • Abstract

      Loading...

    • +

      ES05.05 - Antibody-Drug Conjugates - Where We Stand Today?

      12:26 - 12:38  |  Presenter: Bob T. Li

      • Abstract

      Loading...

    • +

      ES05.06 - HRD/DDR in Lung Cancer: Role and Therapeutic Implications

      12:38 - 12:50  |  Presenter: Lauren Averett Byers

      • Abstract

      Loading...

    • +

      ES05.07 - Live Q&A

      12:50 - 13:00

      • Abstract

      Loading...

  • +

    ES06 - Symptom Management in Lung Cancer

    • 12:00 - 13:00
    • 8/07/2022
    • Location: Lehar 1
    • IASLC CME Accredited
    • Type: Education Session
    • Track: Palliative and Supportive Care
    • +

      Session Moderator

      12:00 - 12:00  |  Presenter: Alberto Alejandro Chiappori

      • Abstract

      Loading...

    • +

      Session Moderator

      12:00 - 12:00  |  Presenter: SARA RAMELLA

      • Abstract

      Loading...

    • +

      ES06.01 - Session Introduction

      12:00 - 12:01  |  Presenter: Alberto Alejandro Chiappori

      • Abstract

      Loading...

    • +

      ES06.02 - Session Introduction

      12:01 - 12:02  |  Presenter: SARA RAMELLA

      • Abstract

      Loading...

    • +

      ES06.03 - The Management of Symptoms with Patients Reported Outcome

      12:02 - 12:14  |  Presenter: Emilio Bria

      • Abstract

      Loading...

    • +

      ES06.04 - Interventional Pulmonology for Managing Dyspnea in Lung Cancer

      12:14 - 12:26  |  Presenter: Semra Bilaceroglu

      • Abstract

      Loading...

    • +

      ES06.05 - Palliative Radiotherapy in the Era of Targeted and Immunotherapy

      12:26 - 12:38  |  Presenter: Lucyna Kepka

      • Abstract

      Loading...

    • +

      ES06.06 - Self-Care for the Clinician Caring for Advanced Cancer Patients: Compassion Fatigue and Burnout

      12:38 - 12:50  |  Presenter: Maria Ftanou

      • Abstract

      Loading...

    • +

      ES06.07 - Innovative Technology/Tools for Smoking Cessation

      12:50 - 12:55  |  Presenter: Lawson Eng

      • Abstract

      Loading...

    • +

      ES06.08 - Live Q&A

      12:55 - 13:00

      • Abstract

      Loading...

  • +

    ES07 - Impact of Tumor Plasticity and Molecular/Immune Adaptations in Treatment Sensitivity and Resistance

    • 12:00 - 13:00
    • 8/07/2022
    • Location: Strauss 1/2
    • IASLC CME Accredited
    • Type: Education Session
    • Track: Tumor Biology and Biomarkers
    • +

      Session Moderator

      12:50 - 13:00  |  Presenter: Benjamin Besse

      • Abstract

      Loading...

    • +

      Session Moderator

      12:50 - 13:00  |  Presenter: Yuko Minami

      • Abstract

      Loading...

    • +

      ES07.01 - Session Introduction

      12:00 - 12:01  |  Presenter: Benjamin Besse

      • Abstract

      Loading...

    • +

      ES07.02 - Session Introduction

      12:01 - 12:02  |  Presenter: Yuko Minami

      • Abstract

      Loading...

    • +

      ES07.03 - NSCLC Persister Cells and Their Role in Treatment Resistance and Disease Progression

      12:02 - 12:14  |  Presenter: Trever Bivona

      • Abstract

      Loading...

    • +

      ES07.04 - Biological Role and Actionability of Molecular/Immune Alterations after Acquired Resistance to Single-Agent and Combination Therapies (Focus on EMT, Includes SCLC)

      12:14 - 12:26  |  Presenter: Sandra Ortiz-Cuaran

      • Abstract

      Loading...

    • +

      ES07.05 - Tumor Cell Plasticity and Histological/Molecular Changes: Focus On Transition from NSCLC to SCLC

      12:26 - 12:38  |  Presenter: Triparna Sen

      • Abstract

      Loading...

    • +

      ES07.06 - Biological Advances in SCLC: Molecular Subtypes, Anti-tumor Immune Responses and Impact on Therapeutics

      12:38 - 12:50  |  Presenter: Helmut Popper

      • Abstract

      Loading...

    • +

      ES07.07 - Live Q&A

      12:50 - 13:00

      • Abstract

      Loading...

  • +

    MA03 - Predicting Outcomes in Patients with Early Disease NSCLC

    • 12:00 - 13:00
    • 8/07/2022
    • Location: Hall C8
    • Not for CME Credit
    • Type: Mini Oral
    • Track: Early Stage Non-small Cell Lung Cancer
    • +

      Session Moderator

      12:00 - 12:00  |  Presenter: Terufumi Kato

      • Abstract

      Loading...

    • +

      Session Moderator

      12:00 - 12:00  |  Presenter: Devayani Niyogi

      • Abstract

      Loading...

    • +

      MA03.01 - Session Introduction

      12:00 - 12:01  |  Presenter: Terufumi Kato

      • Abstract

      Loading...

    • +

      MA03.02 - Session Introduction

      12:01 - 12:02  |  Presenter: Devayani Niyogi

      • Abstract

      Loading...

    • +

      MA03.03 - Predicting Occult Lymph Node Metastasis in Patients With Clinical Stage IA Non-small Cell Lung Cancer: A Prospective Cohort Study

      12:02 - 12:07  |  Presenter: Junghee Lee

      • Abstract

      Loading...

    • +

      MA03.04 - An Integrated Deep Learning Method to Predict Lung Cancer Recurrence Risk for Resected Stage IA NSCLC

      12:07 - 12:12  |  Presenter: Peng Huang

      • Abstract

      Loading...

    • +

      MA03.05 - EGFR mutation Is Not a Risk Factor for Postoperative Recurrence of Lung Adenocarcinoma on Long Follow-up of a Multi-Institutional Cohort

      12:12 - 12:17  |  Presenter: Yuki Matsumura

      • Abstract

      Loading...

    • +

      MA03.06 - Discussant

      12:17 - 12:27  |  Presenter: David Harpole

      • Abstract

      Loading...

    • +

      MA03.06 - Discussant

      12:17 - 12:27  |  Presenter: Betty Tong

      • Abstract

      Loading...

    • +

      MA03.07 - Accurate Intraoperative Diagnosis of Spread Through Air Spaces (STAS) Using a Cryo Embedding Medium Inflation Method

      12:27 - 12:32  |  Presenter: Takashi Eguchi

      • Abstract

      Loading...

    • +

      MA03.08 - Survival Impact of Benchmarking Lung Cancer Surgeons’ Performance by Quality Metrics

      12:32 - 12:37  |  Presenter: Meredith Ray

      • Abstract

      Loading...

    • +

      MA03.09 - Real-World Acute Toxicity and 90-day Mortality in Patients with Stage I Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiotherapy.

      12:37 - 12:42  |  Presenter: Nienke Wolfhagen

      • Abstract

      Loading...

    • +

      MA03.10 - Discussant

      12:42 - 12:52  |  Presenter: Young Tae Kim

      • Abstract

      Loading...

    • +

      MA03.11 - Live Q&A

      12:52 - 13:00

      • Abstract

      Loading...